By proceeding, you agree to our Terms of Use and Privacy Policy.
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders.
23-25 February 2022
Welcome to the 9th Annual Cholangiocarcinoma Foundation Conference. The two-day scientific event and special Patient Day features cutting-edge research, innovative therapies, and the latest education for cholangiocarcinoma professionals and patients.
Event Ended
USA
Paid
Salt Lake City